Skip to content
‹ Back to IndustriesHealthcare

Insurance Providers Should Prioritize Solutions for Streamlining Pre-Authorization Processes

Prior authorization wastes medical and insurance providers’ time and can result in poor patient outcomes. Changes are likely as the federal government reviews legislation. Melanie Musson, a health insurance expert with USInsuranceAgents.com, reminds providers, “Health insurance providers should focus on creating better pre-authorization processes to improve efficiency and patient outcome.” Prior authorization has been…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Prior authorization wastes medical and insurance providers’ time and can result in poor patient outcomes. Changes are likely as the federal government reviews legislation. Melanie Musson, a health insurance expert with USInsuranceAgents.com, reminds providers, “Health insurance providers should focus on creating better pre-authorization processes to improve efficiency and patient outcome.”

Prior authorization has been a standard component of the insurance provider and medical provider relationship for a long time. Recent studies indicate that this system has grown out of control. As a result, insurance providers deciding on claims coverage can waste provider resources and hinder patient access to lifesaving tests and treatments.

State Legislation Leading the Way

Several states have addressed prior authorization problems and passed legislation to improve patient access. For example, in Texas, medical providers who have demonstrated 90% pre-authorization approvals over six months are exempt from obtaining pre-authorization before specific procedures for diagnosing and treating patients.

In another example, Oregon requires insurers to respond to non-emergency pre-authorization requests within two days. Unfortunately, pre-authorization decisions can take two weeks or longer in many areas of the country.

Federal Government Working on Legislation

The federal government is working on legislation to improve prior-authorization procedures. While specific changes and regulations are yet to be established, insurance providers should prepare for significant changes.

The federal government is primarily concerned with Medicare and Medicaid pre-authorization because that’s where they’re most invested and responsible. 

Insurance Provider Response to Probable Regulation Changes

While pre-authorization processes seem to protect insurers from paying for unnecessary procedures and testing, it may also prevent policyholders from accessing essential care. 

That may result in advanced illness that costs the insurer more to treat. In fact, according to the American Medical Association (AMA), about one-third of physicians report that prior authorization requirements have resulted in adverse health outcomes in patients. 

Automation in processing prior authorization is one avenue to consider to improve the current system. That may speed up the process. 

Insurance providers should also consider the pros and cons of building measurable pre-authorization results like Texas has established. Then, insurance providers can reward physicians and health groups that consistently offer necessary and not superfluous treatments and tests by waiving pre-authorization for specific procedures. 

Physicians and practices should be able to build trust with insurers so they can avoid spending valuable resources on paperwork and working through red tape.

While changing rules can cause insurance providers procedural headaches, improving the preauthorization regulation should improve both patient and provider outcomes. 

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

A zero-paid claim line is not automatically an underpayment

A zero-paid claim line is not automatically an underpayment

A zero payment on a claim line isn't automatically an underpayment; contract terms, particularly packaging rules, determine whether zero is correct. Chasing unsupported findings damages credibility with payers and weakens the position of legitimate disputes, so revenue cycle teams must verify the full contract terms and effective dates before treating any payment difference as a finding.

  • 01When a contract packages add-ons into the primary procedure, the add-on line may legitimately show zero payment because it is folded into the primary procedure reimbursement.
  • 02Pursuing payment differences that lack contract support burns credibility with payers and can weaken the team’s position on later disputes, including valid ones.
  • 03Always verify the complete contract terms, fee schedules, carve-outs, amendments, and the specific version in effect on the date of service before treating a payment variance as a recoverable underpayment.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512